ClinicalTrials.gg
RecruitingNCT02398786MDFRUpdated Nov 21, 2024

Myotonic Dystrophy Family Registry

An observational study in Myotonic Dystrophy, Congenital Myotonic Dystrophy and Myotonic Dystrophy 1, sponsored by Myotonic Dystrophy Foundation. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-11-21.

Sponsored by Myotonic Dystrophy Foundation · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,500
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 43 studies in Myotonic Dystrophy with a site in United States — 23 open to participants now, 27 under way, 4 of them phase 3. Myotonic Dystrophy · United States.

Planned enrollment
2nd of 21
3,500 · median 125
Started
2013
with 4 others
Observational
21 of 43
15 open now
Primary completion
2030-02
later than 20 of 26 live
Registered
10th of 43
by date

Among the 43 studies in Myotonic Dystrophy with a site in United States, this one is the 2nd largest by planned enrollment of the 21 observational ones that give a count, is one of 5 that started in 2013, is one of 21 observational ones, reaches primary completion later than 20 of the 26 other live ones, and was the 10th registered.

Myotonic Dystrophy

127 studies on the registry are indexed under Myotonic Dystrophy; 50 are open to participants now.

Browse Myotonic Dystrophy studies →

Open to participants now

23 of the 43 studies in Myotonic Dystrophy with a site in United States are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 35 Myotonic Dystrophy studies recruiting now, 15 (43%) set no upper age limit and 18 (51%) stop at 75 or younger; 22 take children under 18; 8 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Myotonic Dystrophy with a site in United States, or all of them as a file.
02

Study summary

The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.

Read the detailed description

The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) such as disease symptoms and demographic information to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.

The Registry supports trials and studies, making it easier for researchers to explore data and identify possible trial and study participants. It is the first DM registry that gives community members the opportunity to explore anonymous Registry data, to see what the DM community looks like and what others with DM experience. It also provides information on the community of people living with DM, giving researchers and other medical professionals the opportunity to improve how they treat those affected with DM and learn more about how and why certain treatments work and don't work.

03

Conditions studied

  • Myotonic Dystrophy
  • Congenital Myotonic Dystrophy
  • Myotonic Dystrophy 1
  • Myotonic Dystrophy 2
  • Dystrophia Myotonica
  • Dystrophia Myotonica 1
  • Dystrophia Myotonica 2
  • Myotonia Dystrophica
  • Myotonic Dystrophy, Congenital
  • Myotonic Myopathy, Proximal
  • PROMM (Proximal Myotonic Myopathy)
  • Proximal Myotonic Myopathy
  • Steinert Disease
  • Steinert Myotonic Dystrophy
  • Steinert's Disease
  • Myotonia Atrophica

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will volunteer to participate in this study and enter their own information. The study will be advertised through neuromuscular disease clinics and the Myotonic Dystrophy Foundation and Myotonic Dystrophy Family Registry websites.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with congenital, juvenile-onset or adult onset DM1 or DM2 (confirmed by clinical exam or genetic test)

Exclusion criteria

Exclusion Criteria:

  • Not diagnosed with DM, unaffected family members
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,500 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Interventions

  • OtherPatient-entered data

    This registry provides patient-entered data for future clinical trial and study use.

06

What researchers measure

Primary outcomes

  1. Patient reported outcomes

    Number of patients reporting specific symptoms and symptom severity, as well as impacts to quality of life and overall burden of disease in order to inform clinical trial development, understanding of disease for academic, industry and federal agency stakeholders and overall policy decisions. Results will be analyzed in comparison to other registry data and surveys to characterize this disease population cohort and to further define the population.

    Time frame: 36 months

07

Study locations

1 of 1 sites recruiting
  • Myotonic Dystrophy Foundation
    Oakland, California 94612, United States
    Recruiting
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2013, a primary completion of Feb 2030 and a completion of Feb 2030. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2015
First posted
Mar 26, 2015
Start
Feb 2013
Primary completionEst.
Feb 2030
CompletionEst.
Feb 2030
Last update
Nov 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02398786
Lead sponsor
Myotonic Dystrophy Foundation
Responsible party
Sponsor
First posted
Mar 26, 2015
Start date
Feb 2013
Primary completion
Feb 2030 (estimated)
Completion
Feb 2030 (estimated)
Last update
Nov 21, 2024

Study contacts

Sofia Olmos, PhD
Contact
coordinator@myotonicregistry.org
415-800-7777
Tanya Stevenson, EdD, MPH
study chair · Myotonic Dystrophy Foundation

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion